Daniel James Ford

Title: The Innovative Contributions of Daniel James Ford

Introduction

Daniel James Ford is a notable inventor based in Sydney, Australia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific kinase enzymes. With a total of 2 patents to his name, Ford's work is paving the way for advancements in cancer treatment.

Latest Patents

Ford's latest patents include innovative compounds known as pyrimidinone derivatives, which serve as inhibitors of the cell division cycle 7 (Cdc7) kinase enzyme activity. These compounds are crucial in the development of pharmaceutical compositions aimed at treating proliferative disorders, such as cancer. The invention highlights the potential of these derivatives in addressing diseases where Cdc7 kinase activity plays a significant role.

Career Highlights

Currently, Daniel James Ford is associated with Cancer Research Technology Limited, where he continues to focus on groundbreaking research in cancer therapeutics. His work is instrumental in the ongoing fight against cancer, contributing to the development of new treatment options that could improve patient outcomes.

Collaborations

Ford collaborates with esteemed colleagues, including Frederic Elustondo and Mathew L Calder. These partnerships enhance the research efforts at Cancer Research Technology Limited, fostering an environment of innovation and discovery.

Conclusion

Daniel James Ford's contributions to the field of pharmaceuticals, particularly in cancer research, underscore the importance of innovation in medical science. His patents and ongoing work are vital in the quest for effective treatments for proliferative disorders.